How can we maximise the value and use of epidemiological biobanks by harmonising efforts between countries? This is the theme of a conference being held on the 25-27th March in Brussels, Belgium.
Co-organised by PHOEBE (Promoting Harmonisation of Epidemiological Biobanks), P3G (Public Population Project in Genomics) and BBMRI (Biobanking and Biomolecular Resources Research Infrastructure), the conference will cover two overarching themes: Using Biobanks and Maximising the Use of Biobanks.
Recent years have witnessed intense activities targeted towards building a harmonised network of biobanks to support large-scale genomics. Substantial investments in biobanking will continue to evolve and serve large European bioscience, and bioscience worldwide. Many countries envision that biobanks will become a part of their medical research and health care infrastructure. An already impressive number of funded initiatives are working on critical building blocks of the harmonisation and infrastructure agendas. These projects span population-based and special populations (PHOEBE, GENOMEUTWIN, ENGAGE, EUROSPAN, GEHA, PHIME, DIOGENES, etc), disease-specific and tissue banks (DANUBIOBANK, GenOSept, IMPACTS, HYPERGENES, CCPRB, GENPI-ENTB2, ORPHANET, EUROBONET, CONTICANET, TRANSBIG, GENOMEL, etc), infrastructure building (BBMRI, INSTRUCT, INFRAFRONTIER, EATRIS, EATRIN, ELIXIR), harmonisation tools and technologies (MOLPAGE, BIOSAPIENS, Gen2PHEN, MOLTOOLS, ReaDNA, INFOBIOMED, SYMBIOMATICS, etc) and ELSI, society and public health (GeneBanC, Priviledged, PHGEN, TISS.EU, etc). The collective output from these projects have already made significant inroads in biobanking science and in the science of biobanking. This includes work related to identifying key issues, design and management of biobanks, SOPs for sample handing, cataloguing and comparing information, coordinated development of compatible bioinformatics, including systems for access across biobanks of d
|Contact: Elisabeth Shaw|
Norwegian Institute of Public Health